Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.
Robert B KargboPublished in: ACS medicinal chemistry letters (2024)
Recent advancements in medical research have focused on the utilization of entheogens, particularly psilocybin and its related compounds, as therapeutic agents in mitigating cognitive decline and enhancing psychological resilience in patients undergoing anesthesia and sedation. This Patent Highlight integrates findings from three patent applications, each contributing unique insights into the potential applications of these substances in medical settings. The article examines the therapeutic mechanisms, proposed treatment methods, and potential clinical outcomes, offering an overview of this innovative approach to postoperative care.
Keyphrases
- cognitive decline
- patients undergoing
- mild cognitive impairment
- healthcare
- climate change
- social support
- palliative care
- sleep quality
- quality improvement
- pain management
- intensive care unit
- drinking water
- chronic pain
- affordable care act
- mechanical ventilation
- health insurance
- acute respiratory distress syndrome
- patient reported